COVID-19 Vaccine could be released in few days
By Tami Stevenson
The FDA indicated in a report released Tuesday, Pfizer’s coronavirus vaccine could be approved within days - and could be
administered as soon as next week. Moderna would follow close behind as their emergency use authorization (EUA) application was also submitted and their data looks good.
Two doctors that are not affiliated with the vaccine trials told NBC News they think, according to the data in the release by the FDA, the vaccine should be a go.
Dr. William Moss, executive director for the Johns Hopkins Bloomberg School of Public Health International Vaccine Access Center told them he thinks we can be confident in the findings of this trial.
Dr. Greg Poland, director of the Mayo Clinic’s Vaccine Research Group in Rochester, Minnesota, said that based on the information provided in the document, he could “see absolutely no reason why this EUA would not be granted.”
Side effects are common, according to the data. Some trial participants say they experienced more severe symptoms with the vaccine after the second shot, i.e., muscle pain, chills and headache. The FDA stated, however, there were no specific safety concerns identified that would preclude EUA issuance.
The United Kingdom was first to give the go-ahead on the vaccine with Pfizer’s German partner BioNTech reportedly administering the first shot Tuesday, to a 90-year-old woman near London.